UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Completed
Unique ID issued by UMIN UMIN000008853
Receipt No. R000010393
Scientific Title Clinical study on application of covering method with polyglycolic acid sheet (Neoveil) and fibrin glue (Beriplast) for wounds after endoscopic submucosal dissection for colorectal tumors
Date of disclosure of the study information 2012/09/05
Last modified on 2012/12/03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Clinical study on application of covering method with polyglycolic acid sheet (Neoveil) and fibrin glue (Beriplast) for wounds after endoscopic submucosal dissection for colorectal tumors
Acronym study on 'Beri-Neo method' after colorectal ESD
Scientific Title Clinical study on application of covering method with polyglycolic acid sheet (Neoveil) and fibrin glue (Beriplast) for wounds after endoscopic submucosal dissection for colorectal tumors
Scientific Title:Acronym study on 'Beri-Neo method' after colorectal ESD
Region
Japan

Condition
Condition Colorectal adenomas or early colorectal cancers to be resected by endoscopic submucosal dissection (ESD)
Classification by specialty
Gastroenterology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To evaluate the feasibility of covering method with Neoveil and Beriplast for protecting mucosal defects after colorectal ESD.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Phase I,II

Assessment
Primary outcomes The extent of remaining Neoveil on the ulcer bed 8 to 14 days after ESD
Key secondary outcomes procedure time / success rate of covering / complications associated with the procedure / body temperature, the number of white blood cell, the value of C-reactive protein, and the presence of abdominal pain the next day after colorectal ESD.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 Covering ulcer bed made after colorectal ESD with Neoveil and Beriplast
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
100 years-old >
Gender Male and Female
Key inclusion criteria Adult patients who will undergo colorectal ESD at our hospital and have given written informed consent to this study.
Key exclusion criteria 1. Those who fall under the category of contraindication of Neoveil or Beriplast.
Neoveil: those who have systematic complications
Beriplast:
1) those who have a history of anaphylaxis to components of Beriplast or drugs made of bovine lung, such as aprotinin
2) those who are treated with procoagulants (hemocoagulase made from snake venom), antifibrolytic agents, and aprotinin

2. Those who are considered to be inappropriate for this study by doctors
Target sample size 10

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yosuke Tsuji
Organization NTT Medical Center Tokyo
Division name Department of Gastroenterology
Zip code
Address 5-9-22, Higashi-Gotanda, Shinagawa-ku
TEL
Email

Public contact
Name of contact person
1st name
Middle name
Last name
Organization NTT Medical Center Tokyo
Division name Department of Gastroenterology
Zip code
Address
TEL
Homepage URL
Email

Sponsor
Institute NTT Medical Center Tokyo, Department of Gastroenterology
Institute
Department

Funding Source
Organization None
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2012 Year 09 Month 05 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2012 Year 08 Month 30 Day
Date of IRB
Anticipated trial start date
2012 Year 09 Month 10 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2012 Year 09 Month 04 Day
Last modified on
2012 Year 12 Month 03 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000010393

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.